Targeting the Mycobacterium ulcerans cytochrome bc1:aa3 for the treatment of Buruli ulcer

Targeting the Mycobacterium ulcerans cytochrome bc₁:aa₃ for the treatment of Buruli ulcer

Targeting the <i>Mycobacterium ulcerans</i> cytochrome <i>bc</i>₁:<i>aa</i>₃ for the treatment of Buruli ulcer, Published online: 18 December 2018; doi:10.1038/s41467-018-07804-8

Mycobacterium ulcerans is the causative agent of Buruli ulcer (BU). Existing anti-tubercular drugs have been used to treat the condition with varying success. Here, the authors show that a clinical-stage drug candidate for tuberculosis, Q203, is effective at killing M. ulcerans and is a promising therapeutic candidate for BU.

from A via a.sfakia on Inoreader https://ift.tt/2Cj9Sz8